[Efficacy of clinical path in the treatment of patients with rheumatoid arthritis].
Oka
Hiroshi
H
Division of Rheumatology and Allergy, Department of Internal Medicine, St. Marianna University School of Medicine.
Ozaki
Shoichi
S
D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects; D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000009:adverse effects; D001172:Arthritis, Rheumatoid / Q000628:therapy*; D019091:Critical Pathways; D006760:Hospitalization; D006801:Humans; D000069285:Infliximab; D010353:Patient Education as Topic / Q000379:methods; D014397:Tuberculosis, Pulmonary / Q000175:diagnosis / Q000209:etiology / Q000517:prevention & control
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab